Contribution of functional voltage-gated Na+ channel expression to cell behaviors involved in the metastatic cascade in rat prostate cancer: I. Lateral motility

Journal of Cellular Physiology

Volumn 195, Issue 3, 2003, Pages 479-487

  Fraser, S P ^a   Salvador, V ^a,b   Manning, E A ^a,c   Mizal, J ^a,d   Altun, S ^a,e   Raza, M ^a,f   Berridge, R J ^a   Djamgoz, M B A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^e ISTANBUL UNIVERSITY   (Turkey)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITINE; BREVETOXIN; PHENYTOIN; SEA ANEMONE TOXIN; SODIUM CHANNEL; TETRODOTOXIN; VERATRIDINE; VOLTAGE GATED SODIUM CHANNEL;

ANIMAL CELL; ARTICLE; CELL MOTILITY; CHANNEL GATING; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ELECTROPHYSIOLOGY; IN VITRO STUDY; MALE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; RAT;

ACONITINE; ANIMALS; CARCINOMA; CELL DIVISION; CELL MOVEMENT; CNIDARIAN VENOMS; CYTOSKELETAL PROTEINS; CYTOSKELETON; GENE EXPRESSION REGULATION, NEOPLASTIC; ION TRANSPORT; MALE; MARINE TOXINS; NEOPLASM METASTASIS; OXOCINS; PATCH-CLAMP TECHNIQUES; PHENYTOIN; PROSTATIC NEOPLASMS; RATS; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; TETRODOTOXIN; TUMOR CELLS, CULTURED; VERATRIDINE;

EID: 0037731687     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10312     Document Type: Article

References (51)

1. Banyard J, Zetter BR. 1999. The role of cell motility in prostate cancer. Cancer Metast Rev 17:449-458.
2. Battino D, Estienne M, Avanzini G. 1995. Clinical pharmacokinetics of antiepileptic drugs in pediatric-patients. 2. phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine, and felbamate. Clin Pharmacokinet 29:341-369.
3. + channel. Proc Roy Soc (Lond) 248:235-240.
4. Bjorge JD, Jakymiw A, Fujita DJ. 2000. Selected glimpses into the activation and function of Src kinase. Oncogene 19:5620-5635.
5. Cantiello HF, Prat AG, Bonventre JV, Cunningham CC, Hartwig JH, Ausiello DA. 1993. Actin-binding protein contributes to cell volume regulatory ion channel activation in melanoma cells. J Biol Chem 268:4596-4599.
6. Cestèle S, Catterall WA. 2000. Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. Biochimie 82:883-892.
7. + channel α-subunit genes in rat and human prostate cancer cell lines. The Prostate 48:1-14.
8. + channel activity. J Cell Sci 114:2697-2705.
9. Dunning WF. 1963. Prostate cancer in the rat. Monogr Natl Cancer Inst 12:351-369.
10. Fong CJ, Sutkowski DM, Kozlowski JM, Lee C. 1992. Utilization of the Boyden chamber to further characterize in vitro migration and invasion of benign and malignant human prostatic epithelial cells. Invas Metast 12:264-274.
11. + channel activity contributes to rodent prostate cancer migration in vitro. J Physiol 513:131P.
12. Fraser SP, Ding Y, Liu A, Foster CS, Djamgoz MBA. 1999. Tetrodotoxin suppresses morphological enhancement of the metastatic MAT-LyLu rat prostate cancer cell line. Cell Tissue Res 295:505-512.
13. Fraser SP, Grimes JA, Djamgoz MBA. 2000. Effects of voltage-gated ion channel modulators on rat prostatic cancer cell proliferation: Comparison of highly and weakly metastatic cell lines. The Prostate 44:61-76.
14. Freud-Silverberg M, Shainberg A. 1993. Electric stimulation regulates the level of CA-channels in chick muscle culture. Neurosci Lett 151:104-106.
15. + current expressed in the highly metastatic Mat-LyLu cell line of rat prostate cancer. J Cell Physiol 175:50-58.
16. + currents in two prostatic tumor cell lines: Contribution to invasiveness in vitro. FEBS Letts 369:290-294.
17. Hahn C-G, Covault J. 1992. Neural regulation of N-cadherin gene expression in developing and adult skeletal muscle. J Neurosci 12:4677-4687.
18. Heathcote RD. 1989. Acetylcholine-gated and chloride conductance channel expression in rat muscle membrane. J Physiol 414:473-497.
19. Hendrix MJC, Seftor EA, Chu Y-W, Trevor KT, Seftor REB. 1996. Role of intermediate filaments in migration, invasion, and metastasis. Cancer Metast Rev 15:507-525.
20. Hernandez-Alcoceba R, del Peso L, Lacal JC. 2000. The Ras family of GTPases in cancer cell invasion. Cell Mol Life Sci 57:65-76.
21. Isaacs JT, Isaacs WB, Feitz WFG, Scheres J. 1986. Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilites of prostatic cancers. The Prostate 9:261-281.
22. Isom LL, Ragsdale DS, De Jongh KS, Westenbroek RE, Reber BFX, Scheuer T, Catterall WA. 1995. Structure and function of the β2 subunit of brain sodium channels, a transmembrane glycoprotein with a CAM motif. Cell 83:433-442.
23. Itoh K, Stevens B, Schachner M, Douglas Fields R. 1995. Regulated expression of the neural cell adhesion molecule L1 by specific patterns of neural impulses. Science 270:1369-1372.
24. + channel by beta subunit-modulation by a phosphorylation-dependent interaction between the distal C terminus of alpha subunit and cytoskeleton. J Biol Chem 272:14021-14024.
25. Krueger JS, Keshamouni VG, Atanaskova N, Reddy KB. 2001. Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion. Oncogene 20:4209-4218.
26. + channels in human prostate cancer cell lines and their contribution to invasiveness in vitro. Am J Pathol 150:1213-1221.
27. Levine MD, Liotta LA, Stracke ML. 1995. Stimulation and regulation of tumor cell motility in invasion and metastasis. EXS 74:157-159.
28. Linsdell P, Moody WJ. 1995. Electrical activity and calcium influx regulate ion channel development in embryonic Xenopus skeletal muscle. J Neurosci 15:4507-4514.
29. Miller FR, Heppner GH. 1990. Cellular interactions in metastasis. Cancer Metast Rev 9:449-458.
30. Mohler JL. 1993. Cellular motility and prostatic carcinoma metastases. Cancer Metastasis Rev 12:53-67.
31. Mohler JL, Partin AW, Isaacs JT, Coffey DS. 1988. Metastatic potential prediction by a visual grading system of cell motility: Prospective validation in the Dunning R-3327 prostatic adenocarcinoma model. Cancer Res 48:4312-4317.
32. Mycielska M, Fraser SP, Szatkowski M, Djamgoz MBA. 2001. Endocytic membrane activity in rat prostate cancer cell lines: Potentiation by functional voltage-gated sodium channels. J Physiol 531:81P-82P.
33. Parker SL, Tong T, Bolden S, Wingo PA. 1996. Cancer statistics, 1996. Ca Cancer J Clin 46:5-27.
34. Partin AW, Isaccs JT, Treiger B, Coffey DS. 1988. Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey ras oncogene. Cancer Res 48:6050-6053.
35. Partin AW, Schoeniger JS, Mohler JL, Coffey DS. 1989. Fourier analysis of cell motility: Correlation of motility with metastatic potential. Proc Natl Acad Sci USA 86:1254-1258.
36. Peck D, Isacke CM. 1996. CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum. Curr Biol 6:884-890.
37. Powell CT, Gschwend JE, Fair WR, Brittis NJ, Stec D, Huryk R. 1996. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells. Cancer Res 56:4137-4141.
38. Qiu Y, Kung HJ. 2000. Signaling network of the Btk family kinases. Oncogene 19:5651-5661.
39. Rakic P, Komuro H. 1995. The role of receptor/channel activity in neuronal cell migration. J Neurobiol 26:299-315.
40. Rao S, Sikdar SK. 2000. Modification of a subunit of RIIA sodium channels by aconitine. Eur J Physiol 439:349-355.
41. 2+ channels in neuronal cells. Nature 297:79-80.
42. + channel. J Cell Physiol 132:49-56.
43. Schwab A, Oberleithner H. 1996. Plasticity of renal epithelial cells: The way a potassium channel supports migration. Eur J Physiol 432:R87-R93.
44. Sheng M, Kim E. 1996. Ion channel associated proteins. Curr Opin Neurobiol 6:602-608.
45. Silletti S, Yao JP, Pienta KJ, Raz A. 1995. Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells. Int J Cancer 63:100-105.
46. Smith P, Rhodes NP, Shortland AP, Fraser SP, Djamgoz MBA, Ke Y, Foster CS. 1998. Sodium channel protein expression enhances the invasiveness of rat and human prostate cancer cells. FEBS Lett 13:19-24.
47. + channels in cultured glial precursor cells. Eur J Neurosci 3:230-236.
48. Srinivasan Y, Elmer L, Davis J, Bennett V, Angelides K. 1988. Ankyrin and spectrin associated with voltage-dependent sodium channels in brain. Nature 333:177-180.
49. Undrovinas AI, Shander GS, Makielski JC. 1995. Cytoskeleton modulates gating of voltage-dependent sodium-channel in heart. Am J Physiol 38:H203-H214.
50. Verheugen JA, Oortgiesen M, Vijverberg HP. 1994. Veratridine blocks voltage-gated potassium current in human T lymphocytes and in mouse neuroblastoma cells. J Membr Biol 137:205-214.
51. Weisberg E, Sattler M, Ewaniuk DS, Salgia R. 1997. Role of focal adhesion proteins in signal transduction and oncogenesis. Crit Rev Oncogenesis 8:343-358.